FDA
February 24, 2022
Today, the U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults. Jardiance…
Today, the U.S. Food and Drug Administration authorized the marketing of the first condoms specifically indicated to help reduce transmission of sexually transmitted infections (STIs)…
February 22, 2022
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA posted a new resource,…
February 18, 2022
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA is announcing that it…
February 11, 2022
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Feb. 11, the U.S. Food and…
February 11, 2022
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new monoclonal antibody for the treatment of COVID-19 that retains…
The U.S. Food and Drug Administration has been notified by Pfizer that new data have recently emerged regarding its emergency use authorization request for the…
February 9, 2022
Today, the U.S. Food and Drug Administration took new steps aimed at fostering the development of non-addictive alternatives to opioids to manage acute pain and…
February 4, 2022
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Feb. 3, the FDA issued a…
February 4, 2022
One of the U.S. Food and Drug Administration’s top priorities is to improve the health of Americans through better nutrition. We are pleased to see…

